tiprankstipranks
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
H.C. Wainwright downgrades Galectin Therapeutics after MASH trial fails
Premium
The Fly
H.C. Wainwright downgrades Galectin Therapeutics after MASH trial fails
2M ago
Galectin Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Galectin Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
3M ago
Galectin Therapeutics presents three abstracts at AASLD 2024 Liver Meeting
Premium
The Fly
Galectin Therapeutics presents three abstracts at AASLD 2024 Liver Meeting
3M ago
Galectin Therapeutics Reports Increased Q3 Losses
Premium
Company Announcements
Galectin Therapeutics Reports Increased Q3 Losses
3M ago
Galectin Therapeutics sees cash runway through May 15, 2025
PremiumThe FlyGalectin Therapeutics sees cash runway through May 15, 2025
6M ago
Galectin Therapeutics reports Q2 EPS (20c) vs. (15c) last year
Premium
The Fly
Galectin Therapeutics reports Q2 EPS (20c) vs. (15c) last year
6M ago
Galectin Therapeutics Appoints New Chief Medical Officer
Premium
Company Announcements
Galectin Therapeutics Appoints New Chief Medical Officer
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100